DataMeds AI, Inc. Capitalized Contract Cost, Accumulated Impairment
DataMeds AI, Inc. (MEDS) had Capitalized Contract Cost, Accumulated Impairment of $649.18 thousand as of 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Notes
us-gaap:CapitalizedContractCostAccumulatedImpairment · last filed 2026-03-20
- 2025-12-31: Capitalized Contract Cost, Accumulated Impairment $649.18K.
| Period end | Capitalized Contract Cost, Accumulated Impairment |
|---|---|
| 2025-12-31 | $649.18K 10-K · filed 2026-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |